tetralogic pharmaceuticals c
(TLOG:Consolidated Issue listed on NASDAQ Global Market)
John M. Gill CPA
Co-Founder , TetraLogic Pharmaceuticals Corporation
|Age||Total Calculated Compensation||This person is connected to 51 board members in 3 different organizations across 4 different industries.|
See Board Relationships
Mr. John M. Gill, CPA has been the Chief Executive Officer and President of Pharmathene, Inc. since March 12, 2015. Mr. Gill co-founded Tetralogic Pharmaceuticals, Inc. in 2003 and served as its President and Chief Executive Officer until August 12, 2013. Mr. Gill held senior management positions in operations and finance at SmithKline Beecham Corporation and 3 Dimensional Pharmaceuticals. Mr. Gill served as the Chief Financial Officer of 3-dimensional Pharmaceuticals ...
343 Phoenixville PikePhone: 610-889-9900
Malvern, Pennsylvania 19355
Board Members Memberships*
Former Chief Operating Officer, Executive Vice President and Director
Chief Executive Officer, President and Director
Rutgers, The State University of New Jersey
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Marijn E. Dekkers Ph.D.||Chairman of Management Board and Chief Executive Officer|
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|Moshe Manor||Chief Executive Officer, President and Director|
Protalix BioTherapeutics, Inc.
|$93.7K||Compensation as of Fiscal Year 2014.|